A randomized, blinded, placebo-controlled Phase I clinical trial to evaluate the safety and preliminary immunogenicity of a hexavalent Group B Streptococcus conjugate vaccine in healthy individuals aged 18–49 years.

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 9d482e9c0159ab08806b917b8fa697217e9db9c3
First added on: Jan 24, 2026